THURSDAY, SEPTEMBER 19, 2019

13:15 -14:45

PERSPECTIVES ON ENDOMETRIAL AND CERVICAL CANCER:  EXPLORING THE ROLE OF PEMBROLIZUMAB AND OTHER I-O THERAPIES

Hall Europa A
INDUSTRY SPONSORED SATELLITE SYMPOSIUM ORGANIZED BY: Merck

CHAIR:  Fernando Maluf, Brazil

13:15 – 13:25 WELCOME AND PANEL INTRODUCTIONS

Fernando Maluf, Brazil

13:25 – 13:55 ADVANCES IN ENDOMETRIAL CANCER THERAPY – THE COMPLEMENTING ROLES OF MONOTHERAPY AND COMBINATION TREATMENT STRATEGIES

Angélica Nogueira Rodrigues, Brazil

13:55 – 14:25 INNOVATIONS IN CERVICAL CANCER TREATMENT

Krishnansu Tewari, USA

14:25 – 14:45 Q&A AND MEETING SYNOPSIS

Panel and Chair

FRIDAY, SEPTEMBER 20, 2019

13:00 – 14:30

PARP INHIBITION IN OVARIAN CANCER: SETTING A NEW STANDARD OF CARE?

Hall Europa B
INDUSTRY SPONSORED SATELLITE SYMPOSIUM ORGANIZED BY: AstraZeneca

CHAIR:  Fernando Maluf, MD, Brazil

13:00 – 13:05 WELCOME AND INTRODUCTION

Fernando Maluf, MD, Brazil

13:05 – 13:25 FROM DIAGNOSIS TO TREATMENT WITH PARP INHIBITORS

Katy Moore, MD, USA

13:25 – 13:45 USE OF PARP INHIBITORS FOR THE MANAGEMENT OF PSR OVARIAN CANCER

Thomas Herzog, MD, USA

13:45 – 14:05 PRACTICAL GUIDANCE AND THE FUTURE OF CARE

Mansoor Mirza, MD, Denmark

14:05 – 14:30 PANEL DISCUSSION AND AUDIENCE Q&A

Fernando Maluf, MD, Brazil

———–

13:00 – 14:30

IMMUNOTHERAPY AND ANTI VEGF: SYNERGY AND ENHANCED BENEFITS IN OVARIAN CANCER

Hall Europa A

INDUSTRY SPONSORED SATELLITE SYMPOSIUM ORGANIZED BY: Roche

CHAIR:  Angelica Nogueira, MD, Brazil

13:00 – 13:10 WELCOME AND INTRODUCTION

Angelica Nogueira, Brazil

13:10 – 14:10 IMMUNOTHERAPY AND ANTI VEGF: SYNERGY AND ENHANCED BENEFITS IN OVARIAN CANCER

Shannon N. Westin, USA, MD Anderson Cancer Center

14:10 – 14:30 CLOSING REMARKS / QUESTIONS AND ANSWERS

Angelica Nogueira, Brazil